Skip to main content

Table 2 Measures of disease activity for each year from 2004 to 2013 for patients with rheumatoid arthritis monitored with outcome measures in an ordinary outpatient clinic

From: Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway

Year (patients)

ESR (mm/h)

CRP (mg/dl)

28 tender joint count

28 swollen joint count

DAS28-ESR

CDAI

SDAI

Assessor’s global assessment (VAS, mm)

2004

22.3 (16.8)

14.8 (18.9)

4.2 (5.5)

4.1 (4.6)

3.9 (1.4)

14.8 (10.9)

16.2 (11.8)

22.6 (16.1)

(n = 404)

[77.7 %]

[81.2 %]

[87.4 %]

[87.4 %]

[74.3 %]

[85.0 %]

[77.2 %]

[86.6 %]

2005

22.1 (17.4)

13.6 (15.2)

4.0 (5.5)

3.5 (4.1)

3.8 (1.4)

13.5 (10.6)

14.7 (11.5)

19.9 (15.3)

(n = 604)

[80.8 %]

[79.8 %]

[90.2 %]

[90.2 %]

[79.6 %]

[89.4 %]

[78.5 %]

[90.1 %]

2006

22.7 (16.5)

13.0 (13.1)

4.8 (5.7)

3.3 (3.7)

4.0 (1.4)

14.4 (10.4)

15.5 (10.8)

20.1 (16.1)

(n = 620)

[76.6 %]

[78.4 %]

[90.0 %]

[90.0 %]

[75.2 %]

[87.6 %]

[76.0 %]

[88.9 %]

2007

23.3 (18.7)

14.9 (18.0)

4.5 (5.7)

3.3 (4.0)

3.9 (1.4)

13.9 (11.0)

15.7 (11.9)

21.0 (16.3)

(n = 743)

[63.4 %]

[66.8 %]

[72.1 %]

[72.1 %]

[57.9 %]

[67.3 %]

[60.4 %]

[71.3 %]

2008

20.9 (16.2)

10.9 (17.4)

3.6 (4.8)

3.1 (3.7)

3.6 (1.3)

12.2 (10.0)

13.3 (10.6)

17.9 (15.9)

(n = 796)

[62.8 %]

[66.7 %]

[74.9 %]

[74.9 %]

[56.0 %]

[64.1 %]

[58.7 %]

[71.4 %]

2009

19.4 (15.8)

8.4 (14.2)

2.9 (4.6)

2.7 (3.6)

3.3 (1.3)

10.8 (9.4)

11.9 (10.1)

17.0 (16.0)

(n = 969)

[70.6 %]

[74.0 %]

[83.4 %]

[83.4 %]

[64.0 %]

[75.9 %]

[66.3 %]

[81.8 %]

2010

19.1 (15.0)

8.0 (12.6)

2.5 (4.2)

1.9 (3.1)

3.2 (1.3)

9.1 (8.3)

9.8 (8.6)

13.0 (12.7)

(n = 1069)

[80.4 %]

[81.2 %]

[89.9 %]

[89.9 %]

[77.4 %]

[85.4 %]

[77.6 %]

[88.5 %]

2011

18.2 (14.7)

7.1 (12.0)

1.9 (3.4)

1.4 (2.5)

3.0 (1.2)

8.0 (7.4)

8.6 (7.7)

12.9 (13.4)

(n = 1103)

[80.2 %]

[84.0 %]

[90.0 %]

[90.0 %]

[78.5 %]

[87.9 %]

[81.9 %]

[90.1 %]

2012

18.0 (15.6)

7.0 (13.2)

1.5 (3.5)

1.2 (2.5)

2.8 (1.2)

7.1 (7.1)

7.8 (7.5)

10.6 (12.6)

(n = 1113)

[78.0 %]

[83.1 %]

[91.3 %]

[91.3 %]

[75.8 %]

[88.2 %]

[80.6 %]

[91.0 %]

2013

17.2 (14.2)

6.4 (10.6)

1.3 (3.0)

0.8 (1.8)

2.7 (1.1)

6.3 (6.1)

7.0 (6.3)

9.7 (11.4)

(n = 1083)

[76.8 %]

[80.4 %]

[89.8 %]

[89.8 %]

[74.1 %]

[86.1 %]

[76.6 %]

[89.6 %]

P valuea 2004–2013

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

P valuea 2010–2013

0.012

0.007

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

  1. Abbreviations: CDAI: Clinical Disease Activity Index, CRP C-reactive protein, DAS28 Disease Activity Score in 28 joints, ESR Erythrocyte sedimentation rate, SDAI Simplified Disease Activity Index, VAS visual analogue scale, 0–100 mm
  2. Data are mean (SD). The percentages within square brackets represent patients with available data
  3. aLinear regression used to test for differences during follow-up